Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of 18F-Fluoromisonidazole (18F-FMISO) PET Imaging on Evaluation of Hypoxia Before Lu-177 PSMA Treatment for Prostate Cancer

NCT06433063 is registered in ClinicalTrials.gov with Cigdem Soydal as lead sponsor.

NCT NCT06433063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06433063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of 18F-Fluoromisonidazole (18F-FMISO) PET Imaging on Evaluation of Hypoxia Before Lu-177 PSMA Treatment for Prostate Cancer
Lead sponsor
Cigdem Soydal
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2024
Completion date
February 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxia, prostatic neoplasms